Eisai invests in BioArctic's Alzheimer research

bionity.com     Apr 7, 2008          

Eisai Co. Ltd has signed an exclusive licence agreement with Uppsala-based biopharmaceutical company BioArctic Neuroscience for their monoclonal antibody BAN2401, developed as a next-generation ... ... Japanese firm inputs world-leading know-how in next-generation... [read full story]                    


*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies